4411 | VOIS 003 X 0031 | kaiser | 03/27/2015 10:34:43 AM |
3267 | PPJE 002 X 0021 | kaiser | 02/10/2014 2:49:25 PM |
3266 | PPJE 002 | kaiser | 02/10/2014 2:45:31 PM |
3265 | PPJE 0018 nice hits coming in | kaiser | 02/10/2014 2:27:50 PM |
3264 | NXCP .0184 buyers moving back in. This uranium | kaiser | 02/10/2014 2:23:19 PM |
3263 | PPJE 0017 X 0018 nice bid in. Looks ready | kaiser | 02/10/2014 12:39:22 PM |
3262 | LBTG 0007 X 0008 | kaiser | 02/10/2014 11:20:16 AM |
3261 | LBTG 0007 | kaiser | 02/10/2014 11:17:38 AM |
3260 | LBTG 0006 | kaiser | 02/10/2014 11:06:20 AM |
3259 | LBTG 0005's hitting | kaiser | 02/10/2014 10:56:05 AM |
3258 | SREH 0019 X 0021 | kaiser | 02/10/2014 10:35:37 AM |
3257 | SREH 002 expecting news from the company | kaiser | 02/10/2014 10:27:45 AM |
3256 | LBTG 0004 X 0005 | kaiser | 02/10/2014 10:14:39 AM |
3255 | CPXP 0028 | kaiser | 02/10/2014 10:10:54 AM |
3254 | IDVC 002 X 0021 | kaiser | 02/10/2014 9:53:53 AM |
3253 | SREH 002 | kaiser | 02/10/2014 9:40:35 AM |
3252 | CPXP 0023 X 0028 | kaiser | 02/10/2014 9:38:09 AM |
3251 | IDVC 0021 looks like buyers are moving back in. | kaiser | 02/09/2014 10:55:50 PM |
3250 | CPXP 0023 nice move up on Friday. Should move | kaiser | 02/09/2014 10:53:32 PM |
3249 | SREH 0017 company should have an update about the | kaiser | 02/09/2014 10:52:10 PM |
3248 | IRCE 0008 company should have some very nice | kaiser | 02/09/2014 10:48:18 PM |
3247 | LBTG 0004 nice buying on Friday. Chart setting up | kaiser | 02/09/2014 10:46:11 PM |
3246 | CPXP 0025 | kaiser | 02/07/2014 3:54:04 PM |
3245 | LBTG 0005 | kaiser | 02/07/2014 3:23:55 PM |
3244 | LBTG 0004 hitting | kaiser | 02/07/2014 3:19:26 PM |
3243 | LBTG 0003 X 0004 | kaiser | 02/07/2014 3:09:41 PM |
3242 | CPXP 0019 hitting | kaiser | 02/07/2014 3:07:35 PM |
3241 | LBTG 0003 nice hits coming in. Looks ready | kaiser | 02/07/2014 2:52:09 PM |
3240 | CPXP 0017 X 0019 | kaiser | 02/07/2014 2:50:07 PM |
3239 | SREH 002 company should have big news | kaiser | 02/07/2014 2:30:13 PM |
3238 | CPXP 0018 | kaiser | 02/07/2014 2:25:59 PM |
3237 | CPXP 0017 | kaiser | 02/07/2014 2:14:43 PM |
3236 | CPXP 0015 X 0018 | kaiser | 02/07/2014 2:10:33 PM |
3235 | CPXP 0015 hitting | kaiser | 02/07/2014 1:59:25 PM |
3234 | IDVC 0017 X 0022 | kaiser | 02/07/2014 1:47:12 PM |
3233 | CPXP 0013 X 0015 nice bid in. Looks ready | kaiser | 02/07/2014 1:34:30 PM |
3232 | IDVC 0016's going | kaiser | 02/07/2014 1:01:48 PM |
3231 | SREH 002 hitting | kaiser | 02/07/2014 12:26:48 PM |
3230 | SREH 0019 hearing company should have an update | kaiser | 02/07/2014 12:15:29 PM |
3229 | IDVC 0016 hitting | kaiser | 02/07/2014 10:23:03 AM |
3228 | IDVC 0016 looks like buyers are moving back in. A | kaiser | 02/06/2014 10:50:11 PM |
3227 | IRCE 0008 company should have some very good | kaiser | 02/06/2014 10:43:29 PM |
3226 | VMGI 001 | kaiser | 02/06/2014 3:42:05 PM |
3225 | IDVC 0016 | kaiser | 02/06/2014 3:24:52 PM |
3224 | IDVC 0014 X 0016 nice buying | kaiser | 02/06/2014 2:19:09 PM |
3223 | VMGI 0009's going | kaiser | 02/06/2014 2:03:12 PM |
3222 | CPXP 0015 | kaiser | 02/06/2014 12:33:48 PM |
3221 | CPXP 0013 X 0015 | kaiser | 02/06/2014 12:23:41 PM |
3220 | CPXP 0014 nice buying today looks | kaiser | 02/06/2014 12:18:22 PM |
3219 | NVNT 005 X 006 | kaiser | 02/06/2014 12:16:52 PM |
3218 | VMGI 0008 X 0009 | kaiser | 02/06/2014 11:40:55 AM |
Recent Articles
- Transformative Leadership Change at Renault Group Announced
- Deadline for Fortrea Holdings Inc. Investors in Lawsuit Ahead
- Dupixent® Triumphs in Phase 4 Trial Against Xolair® for CRSwNP
- Dupixent vs. Xolair: Breakthrough Findings in Asthma Treatment
- Faruqi & Faruqi Investigates Ibotta's Legal Claims for Investors
- Red Cat Holdings Faces Legal Challenges Amid Investor Concerns
- Investor Alert: Key Updates on Iovance Biotherapeutics Lawsuit
- Investors Alert: Faruqi & Faruqi Advocate for Open Lending Claims
- Compass Diversified Investors Encouraged to Act Before Deadline
- Freedom Holding Corp. Sees Strong Financial Growth in 2025
- Intellia's Lonvo-z Shows Promising Results for HAE Treatment
- Important Update for Rocket Pharmaceuticals Investors
- DoubleVerify Investors Urged to Consider Legal Options Now
- Investing in Zenas BioPharma: What Investors Should Know
- Deadline for NET Power Investors: What's Next After Losses?
- Investors Urged to Act: Krispy Kreme Legal Investigation Update
- Investigating Investor Claims on Avis Budget Group's Financials
- Urgent Investor Insights: Fortrea Holdings Under Scrutiny
- Investor Alert: Examining West Pharmaceutical Services Fraud Claims
- Vital Insights on Napco Security Technologies for Investors
- Urgent Alert: Investors of PepGen Should Act Now
- Critical Update for Civitas Resources Investors Amid Legal Scrutiny
- UroGen Investors Urged to Act Before Class Action Deadline
- Understanding Legal Actions in Securities: Elevance Health Case
- Scatec Concludes Major Wind Power Deal in Egypt's Energy Future
- Scatec Secures Financing for Innovative Solar and Battery Project
- Uncovering Legal Pathways for Investors in Vestis Corporation
- AV-Comparatives Certifies Leading EDR and XDR Solutions for 2025
- Investors Encouraged to Act: Legal Options for Organon Losses
- Investors Alert: TechTarget Faces Class Action Investigation
- AV-Comparatives Unveils 2025 EDR Certification Results
- ZA Miner Unveils Cloud Mining Platform Capitalizing on Trends
- EQT Targets EUR 23 Billion Fund Size for Future Investments
- EQT Announces Ambitious Fund Size Target for EQT XI
- Redtiger Commemorates Five Years of Innovation with Discounts
- Revolutionizing Video Surveillance with AI Innovations
- Snoop Dogg Unveils TryDeathRow.com for a Fresh Cannabis Ride
- Understanding Verekitug's Potency in Fighting Inflammation
- Bitcoin Solaris Set for Major Launch with Exceptional Specs
- Advanced Epcoritamab Therapy Shows Promise for DLBCL Patients
- Vaultro Finance Celebrates Major Milestone in $VLT Token Sale
- Eve Air Mobility Partners with Revo for Urban Air Mobility Boost
- KIWI design Reaches Milestone with One Million Sold Head Straps
- Promising Results with Talquetamab and Teclistamab for Myeloma
- Major Breakthrough in Multiple Myeloma Treatment: TALVEY and TECVAYLI
- Eve Air Mobility Projects Robust Growth for Urban Air Mobility
- Roche Implements New Safety Measures for Elevidys Gene Therapy
- Hisense Embraces FIFA Club World Cup: A New Era for Fans
- Hisense Takes Center Stage at FIFA Club World Cup™ as Partner
- Celebrating Richard Ford: Prix Fitzgerald Laureate 2025